🇺🇸 FDA
Pipeline program

Metformin hydrochloride sustained release tablets

K-2021-001-02

Unknown small_molecule active

Quick answer

Metformin hydrochloride sustained release tablets for Osteoarthritis is a Unknown program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Osteoarthritis
Phase
Unknown
Modality
small_molecule
Status
active

Clinical trials